olivlawolivlaw

olivLaw · US equity research

JBS N.V. JBS

Meat Packing Plants · SIC 2011 · Vertical: Food products (SIC 201x)

12.96USD+6.23% · 1 dayClose 04 Nov 2026

JBS N.V. is the world's largest protein company, with operations in beef, chicken, pork, fish, lamb and eggs, selling to retailers and foodservice customers in about 197 countries. Net revenue reached 86.2 billion USD in 2025, and in the first half of 2026 margins are under pressure from high livestock costs even as revenue keeps growing.

At the close of 04 Nov 2026, JBS N.V. (JBS) stock was 12.96 USD (+6.23% on the day), with P/E 6.9 on diluted EPS of 1.89 USD over the last 12 months, beta 0.31, 52-week range 10.86–18.42 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
unavailable
P/E (TTM)
6.9
Diluted EPS TTM 1.89 · TTM to 31 Dec 2025
E/P (TTM)
14.58%
TTM to 31 Dec 2025
Dividend yield
unavailable
Beta (2y)
0.31
Volatility (1y) 35%
52-week range
10.8618.42

Price history

Loading chart…

Technical reading

RSI (14)
58.5
strong (55–70)
Bollinger (20, 2)
11.90 – 13.27
in the upper half of the band · %B 0.77 · band width 10.9%
SMA 50 / 200
12.44 / 14.07
mixed trend
MACD (12, 26, 9)
0.02 / -0.01
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month+9.0%−1.1%+10.1 pp—
3 months−5.4%−0.5%−4.9 pp—
6 months−22.3%+4.4%−26.7 pp—
Year to date−10.1%+12.3%−22.4 pp—
1 year−3.2%+13.5%−16.8 pp−1.9%
3 yearsunavailable+76.4%unavailable+13.5%
5 yearsunavailable+63.7%unavailable—
Max drawdown (1y)
−41.0%
09 Apr 2026 → 01 Oct 2026
Max drawdown (5y)
−41.0%
09 Apr 2026 → 01 Oct 2026
Compound annual growth (5y)
unavailable
S&P 500 +10.4%

Price returns, dividends excluded.

Quarterly results

ESEF annual reports carry no quarters: the results are annual (below).

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 0 percentile of its own 1-quarter history (min 7.6, median 7.6, max 7.6; quarters with earnings only).

Fiscal years

Fiscal year202320242025
Revenue72.9 bn77.2 bn86.2 bn
Revenue YoYunavailable+5.8%+11.7%
Net income-198.9 m1.8 bn2.0 bn
Net income YoYunavailableunavailable+14.6%
Diluted EPS-0.191.651.89
Diluted EPS YoYunavailableunavailable+14.5%
net %-0.3%2.3%2.3%
Free cash flow876.6 m2.7 bn832.7 m

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
4.6 bn USD
Financial debt
21.1 bn USD
Net debt
16.5 bn USD
Equity
9.5 bn USD
Total assets
45.2 bn USD
Debt / equity
2.21x
Current ratio
1.60x
ROE
22.9%
ROA
4.7%
FCF margin
1.0%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2023
72.9 bn
2024
77.2 bn
2025
86.2 bn

SEC (XBRL)· 25 Mar 2026verified

Cost of revenue
2023
65.0 bn
2024
65.6 bn
2025
74.9 bn

SEC (XBRL)· 25 Mar 2026verified

Gross profit
2023
8.0 bn
2024
11.6 bn
2025
11.3 bn

SEC (XBRL)· 25 Mar 2026verified

Operating income
2023
1.1 bn
2024
4.4 bn
2025
4.2 bn

SEC (XBRL)· 25 Mar 2026verified

Interest expense
2023
1.9 bn
2024
2.4 bn
2025
2.1 bn

SEC (XBRL)· 25 Mar 2026verified

Pre-tax income
2023
-259.7 m
2024
2.7 bn
2025
2.6 bn

SEC (XBRL)· 25 Mar 2026verified

Income tax
2023
-128.0 m
2024
743.4 m
2025
390.5 m

SEC (XBRL)· 25 Mar 2026verified

Net income
2023
-198.9 m
2024
1.8 bn
2025
2.0 bn

SEC (XBRL)· 25 Mar 2026verified

Diluted EPS
2023
-0.19
2024
1.65
2025
1.89

SEC (XBRL)· 25 Mar 2026verified

Balance sheet · USD

Cash
2023
4.6 bn
2024
5.6 bn
2025
4.6 bn

SEC (XBRL)· 25 Mar 2026verified

Inventories
2023
—
2024
5.0 bn
2025
6.1 bn

SEC (XBRL)· 25 Mar 2026verified

Current assets
2023
—
2024
17.1 bn
2025
18.4 bn

SEC (XBRL)· 25 Mar 2026verified

Property, plant & equipment, net
2023
12.9 bn
2024
11.8 bn
2025
13.6 bn

SEC (XBRL)· 25 Mar 2026verified

Goodwill
2023
—
2024
5.4 bn
2025
5.9 bn

SEC (XBRL)· 25 Mar 2026verified

Intangibles (excl. goodwill)
2023
2.0 bn
2024
1.8 bn
2025
1.8 bn

SEC (XBRL)· 25 Mar 2026verified

Total assets
2023
—
2024
40.7 bn
2025
45.2 bn

SEC (XBRL)· 25 Mar 2026verified

Short-term debt
2023
—
2024
2.1 bn
2025
833.1 m

SEC (XBRL)· 25 Mar 2026verified

Long-term debt
2023
—
2024
17.2 bn
2025
20.3 bn

SEC (XBRL)· 25 Mar 2026verified

Current liabilities
2023
—
2024
11.7 bn
2025
11.5 bn

SEC (XBRL)· 25 Mar 2026verified

Equity
2023
9.7 bn
2024
8.1 bn
2025
9.5 bn

SEC (XBRL)· 25 Mar 2026verified

Cash flow · USD

Operating cash flow
2023
2.4 bn
2024
4.2 bn
2025
2.9 bn

SEC (XBRL)· 25 Mar 2026verified

Capex
2023
1.5 bn
2024
1.5 bn
2025
2.1 bn

SEC (XBRL)· 25 Mar 2026verified

Free cash flow
2023
876.6 m ≈
2024
2.7 bn ≈
2025
832.7 m ≈

SEC (XBRL)· 25 Mar 2026derived

Investing cash flow
2023
-1.4 bn
2024
-1.4 bn
2025
-2.3 bn

SEC (XBRL)· 25 Mar 2026verified

Financing cash flow
2023
1.0 bn
2024
-1.4 bn
2025
-1.8 bn

SEC (XBRL)· 25 Mar 2026verified

Dividends paid
2023
448.0 m
2024
759.3 m
2025
1.6 bn

SEC (XBRL)· 25 Mar 2026verified

Computed indicators

Growth

Revenue growth (YoY)
11.7%
computed by olivLawFY 2025
Revenue CAGR 3Y
unavailable
input data missing
Revenue CAGR 5Y
unavailable
input data missing
EBIT growth (YoY)
-5.0%
computed by olivLawFY 2025
Net income growth (YoY)
14.6%
computed by olivLawFY 2025
Net income CAGR 3Y
unavailable
input data missing
Net income CAGR 5Y
unavailable
input data missing
EPS growth (YoY)
14.5%
computed by olivLawFY 2025
EPS CAGR 3Y
unavailable
input data missing
EPS CAGR 5Y
unavailable
input data missing
FCF growth (YoY)
-69.7%
computed by olivLawFY 2025

Profitability

Gross margin
13.1%
computed by olivLawFY 2025
EBITDA margin
unavailable
input data missing
EBIT margin
4.8%
computed by olivLawFY 2025
Net margin
2.3%
computed by olivLawFY 2025
FCF margin
1.0%
computed by olivLawFY 2025

Returns

ROE
25.6%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROA
4.7%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROIC
14.8%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROCE
12.4%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Payout ratio (EPS)
unavailable
input data missing
Payout ratio (FCF)
189.0%
computed by olivLawFY 2025

Balance sheet

Net debt
16.5 bn USD
computed by olivLawbalance sheet at 31 Dec 2025
Net debt / EBITDA
unavailable
input data missing
Debt / equity
2.4x
computed by olivLawbalance sheet at 31 Dec 2025
Interest coverage
2.0x
computed by olivLawFY 2025

Liquidity

Current ratio
1.6x
computed by olivLawbalance sheet at 31 Dec 2025
Quick ratio
1.1x
computed by olivLawbalance sheet at 31 Dec 2025
Cash ratio
0.4x
computed by olivLawbalance sheet at 31 Dec 2025

Cash

Operating cash flow
2.9 bn USD
computed by olivLawFY 2025
Capital expenditure
2.1 bn USD
computed by olivLawFY 2025
Free cash flow
832.7 m USD
computed by olivLawFY 2025
FCF conversion
41.1%
computed by olivLawFY 2025
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
unavailable
input data missing
Days inventory outstanding
27 days
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Days payables outstanding
unavailable
input data missing
Cash conversion cycle
unavailable
input data missing

Market and valuation

Market capitalisation
unavailable
input data missing
Enterprise value
unavailable
input data missing
Market cap / net income TTM
unavailable
input data missing
P/E (TTM)
6.9x
computed by olivLawFY 2025
Earnings yield
14.6%
computed by olivLawFY 2025
P/B
unavailable
input data missing
P/S
unavailable
input data missing
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
input data missing
EV/Sales
unavailable
input data missing
P/FCF
unavailable
input data missing
FCF yield
unavailable
input data missing
Dividend yield
unavailable
input data missing
Shareholder yield (distributions)
unavailable
input data missing

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Insufficient data
What is missing
  • score weight coverage: 47.9% of at least 60%

A scoring methodology on indicators and valuation, not investment advice.

Closing price

12.96 USD

04 Nov 2026Source: olivLaw, closing series

Market cap: unavailable

Key indicators

Market capitalisation
unavailable
input data missing
P/E (TTM)
6.9x
computed by olivLawFY 2025
P/B
unavailable
input data missing
EV/EBITDA
unavailable
input data missing
ROE
25.6%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Net margin
2.3%
computed by olivLawFY 2025
Revenue growth (YoY)
11.7%
computed by olivLawFY 2025
Dividend yield
unavailable
input data missing

Coverage and freshness

26/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 31 Dec 2025
Latest balance sheet date: 31 Dec 2025
Source: SEC (XBRL)published 25 Mar 2026
verified 78

Score by group

48% · Insufficient data

Estimated value range

Low
40.65
USD per share
Mid
47.01
USD per share
High
68.49
USD per share
Price: 12.96 USD
The price is below the range
Potential to the central value: 262.8% (value / price − 1)
Margin of safety: 72.4% (1 − price / value)
Agreement between methods: single method · 1 methods used · 1 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 40.65 – 68.49 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)unavailable · input data missing
  • Peers: EV/EBITDAunavailable · input data missing
  • Peers: P/E40.65 – 68.49 (Mid 47.01)
    5 companies used · median multiple 24.9x · quartiles 21.5x – 36.2x
    HRL, PPC, SFD, TSN, WYHG
  • Dividend discount (DDM)unavailable · input data missing
Multiple comparisons use the SIC vertical: Food products (SIC 201x)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Insufficient data

Minimum-evidence gate: score weight coverage: 47.9% of at least 60%

FactorValueScoreWeight used
ROIC · Quality14.8%80 (vs peers)22%
Net margin · Quality2.3%43 (vs peers)13%
FCF conversion · Quality41.1%16 (on a fixed band)13%
Revenue CAGR 3Y · Growthunavailableunavailable—
EPS CAGR 3Y · Growthunavailableunavailable—
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheet2.0x7 (on a fixed band)13%
Current ratio · Balance sheet1.6x66 (on a fixed band)9%
P/E (TTM) · Valuation6.9x100 (vs peers)22%
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuationunavailableunavailable—
Shareholder yield (distributions) · Returnsunavailableunavailable—
Payout ratio (FCF) · Returns189.0%0 (on a fixed band)9%

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet31/100 · 2/3 factors with a value
  • Growth· partialunavailable · 0/2 factors with a value
  • Quality52/100 · 3/3 factors with a value
  • Returns· partial0/100 · 1/2 factors with a value
  • Valuation· partial100/100 · 1/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

JBS N.V. (JBS). Latest full fiscal year: 2025; data up to 2025-12-31.

Figures computed from the financial statements: revenue 86.2 bn USD in 2025; YoY growth 11.7%; net margin 2.3%; ROE 25.6%.

The estimated value range is 40.65–68.49 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 47.01 USD, the price of 12.96 USD leaves a potential of 262.8% (value / price − 1) and a margin of safety of 72.4% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

Insufficient data for a verdict (score weight coverage: 47.9% of at least 60%).

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • ROIC: 14.8%
  • P/E (TTM): 6.9x
  • The price is below the estimated value range

What contradicts it

  • FCF conversion: 41.1%
  • Interest coverage: 2.0x
  • Payout ratio (FCF): 189.0%

Not assessed (insufficient data or a ratio without meaning): Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, EV/EBITDA, FCF yield, Shareholder yield (distributions).

Versus the vertical median

Food products (SIC 201x) · same industry group (3-digit SIC) · compared with 7 companies

Multiples and returns vs the median

P/E
6.9x
vertical median 30.6x
below median (−77.6%)
EV/EBITDA
—
vertical median —
P/S
—
vertical median 0.5x
P/B
—
vertical median 1.2x
ROE
25.6%
vertical median 4.8%
above median (+430.5%)
Net margin
2.3%
vertical median 2.8%
below median (−16.7%)
EBIT margin
4.8%
vertical median 4.0%
above median (+21.4%)
Revenue YoY
11.7%
vertical median 3.3%
above median (+255.3%)
Net debt/EBITDA
—
vertical median -0.1x
Dividend yield
—
vertical median 5.1%

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
SFDSmithfield Foods, Inc.7.8 bn8.613.4%5.9%+9.8%−9% / unavailable
PPCPilgrim’s Pride Corporation6.9 bn21.58.6%1.7%+3.5%−24% / +13%
MAMAMama’s Creations, Inc.629.4 m78.17.5%3.5%+39.2%+18% / +230%
WYHGWing Yip Food Holdings Group Limited200.3 m24.94.8%5.9%−6.5%+8% / unavailable
BRIDBridgford Foods Corporation49.3 m—-12.3%-6.1%+3.3%−32% / −49%
TSNTyson Foods, Inc.—37.03.2%1.0%+2.1%+3% / +28%
JBSJbs N.V.—6.925.6%2.3%+11.7%−3% / unavailable
HRLHormel Foods Corporation—36.24.3%2.8%+1.6%−2% / −26%

1- and 3-year price returns: for JBS from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Scenarios are not available. input data missing

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

JBS N.V. is the world's largest protein company, with operations in beef, chicken, pork, fish, lamb and eggs, selling to retailers and foodservice customers in about 197 countries 1. Net revenue reached 86.2 billion USD in 2025 1, and in the first half of 2026 margins are under pressure from high livestock costs even as revenue keeps growing 23.

SWOT

Strengths

  • The group is the largest protein producer in the world, with large capacity and distribution across hundreds of markets 1.
  • Geographic and protein diversification cushions the effect of local shocks on revenue 12.
  • Experience integrating complex international acquisitions provides a solid base for growth 1.

Weaknesses

  • Margins in North American beef stayed negative in the first half of 2026 3.
  • Leverage is above the company's long-term target, which narrows its room for manoeuvre 3.
  • Revenue is sensitive to livestock and feed prices, which the company can pass on to customers only partly 1.

Opportunities

  • Expansion of prepared and branded products in the US and Europe could improve margins over the longer term 13.
  • Investments in Middle Eastern markets linked to halal consumption could open new sales channels 1.
  • Entry into the egg sector through Mantiqueira could add a new revenue line 1.

Threats

  • Animal disease outbreaks can restrict exports and reduce demand for the company's products 1.
  • Shifts in consumer preferences and negative perceptions of food safety can affect sales 1.
  • Volatility in cattle and feed prices remains a threat to margins 13.

Risks

  • Raw material priceshigh

    Margins depend on the price of livestock and feed, which varies widely and is hard to control 1.

  • Animal diseaseshigh

    Outbreaks such as avian influenza can halt exports and weigh on demand, with significant effects on results 1.

  • Food safetymedium

    Product contamination can lead to recalls, legal proceedings and loss of brand confidence 1.

  • Indebtednessmedium

    Debt is above target and interest costs have risen, which could limit investment 3.

  • Dual-class share structurelow

    Voting control is concentrated with holders of Class B shares, limiting the influence of other shareholders 1.

Investment thesis

What would need to be true (bull case)

  • If margins in beef and value-added products recover, results could return toward fiscal 2025 levels 13.
  • Global scale and protein diversification can support revenue even when one segment is under pressure 12.
  • Growing demand for branded and prepared products could reduce dependence on commodity prices 3.

What would break the thesis

  • If cattle supply stays tight, North American beef margins could remain negative for an extended period 3.
  • Debt above target may limit financial flexibility if profitability does not return 3.
  • Export restrictions and disease outbreaks can abruptly reduce revenue in key markets 1.

What to watch

  • Trend in North American beef margins after imports of live cattle from Mexico resumeQ3 2026
  • Net leverage relative to the long-term targetQ3 2026
  • Effect of the Souderton and Memphis plant closures on costs2027
  • Results from the Oman and Saudi Arabia investments and completion of the Oman transactionnext 10-K

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

JBS N.V., a Dutch company based in Amstelveen, became the holding entity of JBS S.A. of Brazil through a 2025 restructuring, and its Class A shares trade on the NYSE under the symbol JBS since June 2025 1. The group was founded in 1953 and grew through major acquisitions including Swift, PPC and Seara 1. It produces and sells fresh and frozen meat, value-added and branded products, and entered the egg sector in 2025 through Mantiqueira 1.

The company operates through seven reportable segments in fiscal 2025: Brazil, Seara, Beef North America, Pork USA, Pilgrim's Pride, Australia and Miscellaneous 1. From 2026 quarterly reporting uses six segments, with Miscellaneous no longer reported separately 2. Brands include Swift, Pilgrim's Pride, Seara, Friboi, Moy Park and Primo, and production sites are located close to raw material supply and consumer markets 1.

Quarterly results are reported under IFRS, and the adjusted EBITDA measure is also presented under USGAAP in the earnings release 3. In 2026 the company announced investments in Oman and Saudi Arabia aimed at the halal market, while new US facilities for ready-to-eat products were also announced 1.

Segments

JBS Beef North America

The North American beef segment reported record sales in the second quarter of 2026, but margins stayed negative due to tight supply of live cattle 3. The company announced the closure of two plants, in Souderton and Memphis, with production to be absorbed by other US plants 3.

Pilgrim's Pride

Pilgrim's Pride saw firm chicken demand across all regions, but profitability declined year on year due to lower commodity prices 3. The US prepared foods business grew both sales and margins 3.

JBS Brazil

JBS Brazil reported record second-quarter sales, supported by higher prices and volumes in exports and the domestic market 3. The average live cattle price rose 12% compared with the second quarter of 2025, yet EBITDA was the highest for a second quarter 3.

Market context

The protein market is fragmented and sensitive to live animal price cycles, animal disease and export regulation 1. Sales are dominated by the United States, which accounted for 51% of net revenue in fiscal 2025, followed by South America at 29% 1. Export demand from Asia and the Middle East remains important, with Asia representing 50% of export revenue in 2025 1.

Market pressure also comes from softening consumer demand: in the US domestic pork demand weakened as inflation pressured consumers, although exports rose 4.7% in January through May 2026 3. On the supply side, restrictions on live cattle imports from Mexico have constrained deliveries to the US market 3.

Trends

  • Live cattle price cycleheadwind

    Live cattle prices have risen much faster than finished product prices, compressing beef margins in the US and Australia 3. If supply stays tight, margin pressure could persist.

  • Demand for value-added productstailwind

    Growth in prepared and branded products in the US, Brazil and Europe supports revenue and helps stabilise margins, according to the earnings release 3.

  • Animal health and trade restrictionsmixed

    Avian flu outbreaks and export restrictions can interrupt deliveries to key markets, as happened in Brazil in 2025 1. The impact depends on how long and how wide the restrictions are.

  • Financing costs and debtheadwind

    Interest expense has risen and leverage remains above the long-term target, limiting financial flexibility if margins do not improve 3.

Competitive position

Competition in meat comes from global and regional players, and the group's advantage lies in production scale and geographic diversification across several protein types 1. Price pressure is most visible in chicken and pork, where prices are volatile 1.

The company cites competition as a risk that can affect market share and profitability, and differentiation through brands and value-added products is its strategic response 1. In export markets competition can intensify when rivals' products are contaminated or recalled 1.

  • Tyson FoodsTSN

    US meat and chicken producer, named in the sources as a former supplier of the Brazilian and Mexican poultry operations the group acquired 1.

  • Marfrig Global Foods

    Brazilian meat company from which the group acquired the Seara and Moy Park businesses 1.

  • Cargill

    Privately held US company from which the group acquired its pork business in 2015 1.

  • Danish Crown

    Danish meat cooperative from which the group acquired Plumrose USA and Tulip 1.

News & filings

In the press

No news in our archive over the last 180 days.

SEC filings

Sources

  1. [1] Form 20-F, fiscal year ended 2025-12-31 · SEC / JBS N.V. · 25 Mar 2026
  2. [2] Form 10-Q, quarter ended 2026-06-30 · SEC / JBS N.V. · 10 Aug 2026
  3. [3] Form 8-K, results release (exhibit 99.1) · SEC / JBS N.V. · 11 Aug 2026

Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.